The Tricky Business of Managing Conflicts of Interest in Medical Journals
This article was originally published in SRA
Information published in medical journals plays an important role in shaping therapeutic choices and can inform regulatory decisions. In the interest of patient care, medical literature must be objective and free from biases introduced by conflicts of interest on the part of authors.
You may also be interested in...
The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with three new products including Novartis's Beovu for treating neovascular (wet) age related macular degeneration. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).
Now that the European Medicines Agency has finalized its formal safety review procedure into Xeljanz, Pfizer is telling health care professionals what precautions they must take when prescribing the drug.